Lower Allele Frequency of TERT -rs2242652 in Sub-Saharan African Populations Compared With American Populations and Hepatocellular Carcinoma Risk
JCO Global Oncology · 2026-03 · 12 (3)
DOI: 10.1200/go-25-00446 ↗Kurz gefasst
Fachartikel in der Zeitschrift JCO Global Oncology, 2026-03. Verfasst von Perapa Chotiprasidhi und 33 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Telomerase, Liver Neoplasms. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NCATS NIH HHS.
Abstract (Originalsprache)
PURPOSE Hepatocellular carcinoma (HCC) is the third leading cause of cancer-related deaths worldwide. The higher incidence and earlier onset of HCC in sub-Saharan Africa suggest a potential role for a genetic predisposition. This study evaluated the association of TERT -rs2242652-(A), a variant linked to lower HCC risk, with HCC in populations from Ghana, Nigeria, and Cameroon, compared with a population from the United States. METHODS The study included 537 patients with HCC: United States (n = 348), Ghana (n = 79), Nigeria (n = 43), and Cameroon (n = 67). The control group had 2,872 cancer-free individuals: United States (n = 2,399), Ghana (n = 323), Nigeria (n = 85), and Cameroon (n = 65). Whole-exome sequencing was conducted using germline DNA, and data for TERT -rs2242652 were analyzed. Odds ratios (ORs) and 95% CIs were calculated using unconditional logistic regression. Chi-square tests assessed protective allele frequencies. RESULTS In the US cohort, TERT -rs2242652 was significantly associated with lower HCC risk (OR, 0.75 [95% CI, 0.58 to 0.96]; P = .02), with an allele frequency of 18.8% (15.4% in HCC cases v 19.3% in controls). In the combined sub-Saharan African population, no significant association was observed, but there was a trend toward decreased HCC risk (OR, 0.80 [95% CI, 0.53 to 1.22]; P = .29), with an allele frequency of 12.2% (10.6% in HCC cases v 12.9% in controls). Separate analyses of Ghanaian, Nigerian, and Cameroonian populations showed similar nonsignificant trends. The protective allele frequency in the combined African populations was significantly lower than in the US cohort ( P < .0001). CONCLUSION In sub-Saharan African populations, there was a lower frequency of the HCC protective allele TERT -rs2242652 compared with European Americans. These findings underscore the importance of multiethnic genetic studies in understanding population differences in HCC risk and developing prevention strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Medicine, Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN.
- School of Medicine, University of Puerto Rico-Medical Sciences Campus, San Juan, Puerto Rico.
- Department of Internal Medicine, Cape Coast Teaching Hospital, Cape Coast, Ghana.
- Department of Quantitative Health Sciences, Division of Computational Biology, Mayo Clinic, Rochester, MN.
- Department of Medicine and Therapeutics, School of Medicine, University of Health and Allied Sciences, Ho, Ghana.
- Department of Medicine and Therapeutics, University of Ghana Medical School, Accra, Ghana.
ORCID-Profile: Perapa Chotiprasidhi, Yvonne Ayerki Nartey, Hunter B Miller, Adrienne F Gefre, Jun Ma, Adwoa Agyei-Nkansah, Mary Afihene, Amoako Duah, Shadrack Asibey, Joshua Ayawin, Jun Wang, Yinan Zheng, Claudia Hawkins, Robert Murphy, Godwin Imade, Edith Okeke, Alani Akanmu, Albert Nyanga, Mark Topazian, Kimberlee Kossick, Jose D Debes, Lewis R Roberts, Kirk J Wangensteen
Förderung
- NCI NIH HHS
- NCATS NIH HHS
Zitieren
APA
Chotiprasidhi, P., Gonzalez Umpierre, V. P., Nartey, Y. A., Miller, H. B., Gefre, A. F., Sato-Espinoza, K., O'Brien, D., Ma, J., Awuku, Y., Agyei-Nkansah, A., Afihene, M., Duah, A., Bampoh, S., Asibey, S., Ayawin, J., Wang, J., Zheng, Y., Hou, L., Hawkins, C., …, & Wangensteen, K. J. (2026). Lower Allele Frequency of TERT -rs2242652 in Sub-Saharan African Populations Compared With American Populations and Hepatocellular Carcinoma Risk. JCO Global Oncology, 12(3). https://doi.org/10.1200/go-25-00446
Vancouver
Chotiprasidhi P, Gonzalez Umpierre VP, Nartey YA, Miller HB, Gefre AF, Sato-Espinoza K, et al. Lower Allele Frequency of TERT -rs2242652 in Sub-Saharan African Populations Compared With American Populations and Hepatocellular Carcinoma Risk. JCO Global Oncology. 2026;12(3). doi:10.1200/go-25-00446
BibTeX
@article{Chotiprasidhi2026,
author = {Chotiprasidhi, Perapa and Gonzalez Umpierre, Viviana P and Nartey, Yvonne Ayerki and Miller, Hunter B and Gefre, Adrienne F and Sato-Espinoza, Karina and O'Brien, Daniel and Ma, Jun and Awuku, Yaw and Agyei-Nkansah, Adwoa and Afihene, Mary and Duah, Amoako and Bampoh, Sally and Asibey, Shadrack and Ayawin, Joshua and Wang, Jun and Zheng, Yinan and Hou, Lifang and Hawkins, Claudia and Murphy, Robert and Imade, Godwin and Okeke, Edith and Akanmu, Alani and Lesi, Olufunmilayo and Plymoth, Amelie and Nyanga, Albert and Nyah, Norah and Topazian, Mark and Kossick, Kimberlee and Boardman, Lisa A and Debes, Jose D and Roberts, Lewis R and Antwi, Samuel O and Wangensteen, Kirk J},
title = {Lower Allele Frequency of TERT -rs2242652 in Sub-Saharan African Populations Compared With American Populations and Hepatocellular Carcinoma Risk},
journal = {JCO Global Oncology},
year = {2026},
volume = {12},
number = {3},
doi = {10.1200/go-25-00446}
}
EUVIMED